Efficacy and safety of MIL60 compared with bevacizumab in advanced or recurrent non-squamous non-small cell lung cancer: a phase 3 randomized, double-blind study
Title:
Efficacy and safety of MIL60 compared with bevacizumab in advanced or recurrent non-squamous non-small cell lung cancer: a phase 3 randomized, double-blind study
Author:
Wan, Rui Dong, Xiaorong Chen, Qun Yu, Yan Yang, Shujun Zhang, Xiaochun Zhang, Guojun Pan, Yueyin Sun, Sanyuan Zhou, Chengzhi Hong, Wei Zhao, Hui Yang, Lei Huang, Linian Wu, Rong Zang, Aimin Ma, Rui Wu, Lin Lv, Dongqing Fu, Xiuhua Han, Jianguo Li, Wenxin Duan, Jianchun Wang, Kai Jiang, Ou Chen, Yinglan Guo, Zhongliang Gao, Hongjun Wen, Juyi Wang, Shubin Zhao, Enfeng Li, Gaofeng Yue, Lu Liang, Li Zeng, Aiping Wang, Xiaoshan Zhu, Yuxi Pan, Hongming Dai, Zhaoxia Feng, Weineng Zhao, Guofang Lin, Chuan Li, Chong Li, Na Bao, Yangyi Li, Yinyin Su, Yanjun Zhao, Min Fang, Haohui Zhu, Yulong Zhang, Yu Ding, Lieming Wang, Yang Yuan, Xiaobin Wang, Jie